Literature DB >> 2318583

Corneal epithelial barrier function after oxybuprocaine provocation in diabetics.

T R Stolwijk1, J A van Best, J P Boor, H H Lemkes, J A Oosterhuis.   

Abstract

Corneal epithelial permeability for fluorescein was determined after provocation by a local anesthetic in 18 non-insulin-dependent diabetes mellitus (NIDDM) patients, 23 insulin-dependent diabetes mellitus (IDDM) patients, and 22 healthy controls to evaluate the corneal epithelial barrier function in diabetes. All volunteers had Oxybuprocaine instilled into one eye and saline into the other eye. The epithelial permeability values were determined by fluorophotometry, and the ratio between both eyes was calculated for each individual. The mean permeability values of the saline-instilled eyes in the diabetic patients did not differ significantly from those in the healthy controls (P greater than 0.2). The individual ratios between Oxybuprocaine- and saline-instilled eyes in the NIDDM and IDDM patients differed significantly from those in the healthy controls (mean ratios: 2.6, 1.9, and 1.0, respectively; P less than 0.002). The permeability ratios and the percentage glycosylated hemoglobin (HbAlc) were linearly correlated in the NIDDM patients but not in the IDDM patients (r = 0.73, P less than 0.001, and r = 0.09, P greater than 0.68, respectively). The results showed that the corneal epithelial barrier function in the diabetic patients was not impaired compared with that in the healthy controls. After provocation by a local anesthetic, the barrier function was impaired in the diabetic patients only.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318583

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  Tear secretion and tear film function in insulin dependent diabetics.

Authors:  M Goebbels
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Determination of basal tear turnover in insulin-dependent diabetes mellitus patients by fluorophotometry.

Authors:  T R Stolwijk; J A van Best; H H Lemkes; R J de Keizer; J A Oosterhuis
Journal:  Int Ophthalmol       Date:  1991-11       Impact factor: 2.031

Review 3.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.